https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-902019-02-27 00:00:002019-02-27 00:00:00Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-857
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-8572019-02-19 00:00:002019-07-01 08:21:29Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-06 / Front Oncol 2019;9:50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-06 / Front Oncol 2019;9:502019-02-06 00:00:002019-02-06 00:00:00On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-01 / Immunotherapy 2019 Feb;11(2):75-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-01 / Immunotherapy 2019 Feb;11(2):75-792019-02-01 00:00:002019-02-01 00:00:00The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-23 / Cancer Gene Ther. 2019 09;26(9-10):282-291
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-23 / Cancer Gene Ther. 2019 09;26(9-10):282-2912019-01-23 00:00:002019-01-23 00:00:00Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-12 / Life Sci. 2019 Feb;219:136-143
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-12 / Life Sci. 2019 Feb;219:136-1432019-01-12 00:00:002019-01-12 00:00:00Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-07 / Int. J. Cancer 2019 Jun;144(11):2867-2879
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-07 / Int. J. Cancer 2019 Jun;144(11):2867-28792019-01-07 00:00:002019-01-07 00:00:00An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-01 / Klin Onkol 2019;32(1):70-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-01 / Klin Onkol 2019;32(1):70-742019-01-01 00:00:002019-01-01 00:00:00Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-01 / Crit Rev Immunol 2019;39(3):211-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-01 / Crit Rev Immunol 2019;39(3):211-2212019-01-01 00:00:002019-01-01 00:00:00Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-01 / Methods Mol. Biol. 2019;1884:317-333
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-01 / Methods Mol. Biol. 2019;1884:317-3332019-01-01 00:00:002019-01-01 00:00:00A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
